| the future of microbiome‐based therapeutics EL Gulliver, RB Young, M Chonwerawong, GL D'Adamo, T Thomason, ... Alimentary Pharmacology & Therapeutics 56 (2), 192-208, 2022 | 31 | 2022 |
| Key technologies for progressing discovery of microbiome-based medicines RB Young, VR Marcelino, M Chonwerawong, EL Gulliver, SC Forster Frontiers in microbiology 12, 685935, 2021 | 20 | 2021 |
| Disease-specific loss of microbial cross-feeding interactions in the human gut VR Marcelino, C Welsh, C Diener, EL Gulliver, EL Rutten, RB Young, ... Nature Communications 14 (1), 6546, 2023 | 15 | 2023 |
| Extensive genome analysis identifies novel plasmid families in Clostridium perfringens EL Gulliver, V Adams, VR Marcelino, J Gould, EL Rutten, DR Powell, ... Microbial genomics 9 (4), 000995, 2023 | 5 | 2023 |
| Temperate gut phages are prevalent, diverse, and predominantly inactive S Dahlman, L Avellaneda-Franco, C Kett, D Subedi, RB Young, JA Gould, ... bioRxiv, 2023.08. 17.553642, 2023 | 3 | 2023 |
| The broccoli-derived antioxidant sulforaphane changes the growth of gastrointestinal microbiota, allowing for the production of anti-inflammatory metabolites SA Marshall, RB Young, JM Lewis, EL Rutten, J Gould, CK Barlow, ... Journal of Functional Foods 107, 105645, 2023 | 2 | 2023 |
| expam—high-resolution analysis of metagenomes using distance trees SM Solari, RB Young, VR Marcelino, SC Forster Bioinformatics 38 (20), 4814-4816, 2022 | 1 | 2022 |
